Using a computational “digital twin” model, researchers mapped the gene networks controlling cell differentiation. They ...

Uncover how stress and sleep patterns influence cancer risk and learn lifestyle changes that may help reduce colorectal ...

[23] The mechanisms that underlie the protective effect of estrogens on colorectal carcinogenesis are not completely understood, although both direct effects on the ERs expressed in colonocytes ...

Despite advancements in cancer treatment technologies, most therapies share a common goal: eliminating cancer cells. However, ...

Dec. 23, 2024 — A research team has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them ...

One’s biological age, which measures the body’s physiological state, may help predict who is at risk for developing colon ...

Colon cancer screening is only effective if you complete the test. With 53,000 Americans expected to die from colon cancer in ...

Stenoparib is under clinical development by Allarity Therapeutics and currently in Phase I for Colon Cancer. According to GlobalData, Phase I drugs for Colon Cancer have a 56% phase transition success ...

Ropidoxuridine is under clinical development by Shuttle Pharmaceuticals and currently in Phase I for Colon Cancer.

Biopsies yielded enough tissue for molecular and histopathological analyses. Conclusions: In summary, chromoendoscopy in mice allows monitoring of the development of colitis and colon cancer with high ...